Proteome Sciences plc (LON:PRM – Get Free Report) shares were up 11.4% on Friday . The company traded as high as GBX 5 ($0.06) and last traded at GBX 5 ($0.06). Approximately 234,559 shares were traded during mid-day trading, an increase of 33% from the average daily volume of 176,457 shares. The stock had previously closed at GBX 4.49 ($0.06).
Proteome Sciences Price Performance
The stock’s fifty day moving average price is GBX 3.89 and its two-hundred day moving average price is GBX 3.27. The firm has a market capitalization of £14.37 million, a price-to-earnings ratio of -3.52 and a beta of 0.07. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- 3 Small Caps With Big Return Potential
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Buy P&G Now, Before It Sets A New All-Time High
- DuPont’s Electronics Spinoff: The Start of Something Big
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.